Request a Quote
Part detail

RFQ For NDC00186-1012-13 NSN part by Astra Pharmaceuticals Lp with NSN 6505011699573

NDC00186-1012-13NSN6505-01-169-9573CAGE04473

Dopamine Hydrochlor

Detailed description

NDC00186-1012-13 procurement notes

Thank you for having an interest in part number NDC00186-1012-13, an item from Astra Pharmaceuticals Lp (CAGE Code 10001) that is listed with the description - Support. Be sure to review the details provided on this page, and should you wish to move forward with procurement, fill out and submit the Request for Quote (RFQ) form provided below at your earliest convenience.

If you also require other items from FSC or wish to speak with staff directly, do not hesitate to give us a call or email at any time. We are ready to support you with competitive options for part number NDC00186-1012-13and other items of interest, so be sure to get in touch today!

Specifications

Reference data

Manufacturer
Astra Pharmaceuticals Lp
Part number
NDC00186-1012-13
NSN
6505-01-169-9573
NIIN
01-169-9573
FSC
6505 Drugs and Biologicals
CAGE code
04473
INC code
—
Country
USA
Part type
Dopamine Hydrochlor
Sub part type
—
Specification
—
Multi-line procurement

Sourcing more than one part?

Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.

Compliance
  • AS9120:2025· Aerospace QMS
  • ISO 9001:2015· Quality Management
  • FAA AC 00-56B· Voluntary Industry Distributor Accreditation
  • U.S. ONLY· Fulfillment

NSN Information for Part Number NDC00186-1012-13 with NSN 6505-01-169-9573, 6505011699573

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505011699573

Item Description:

Dopamine Hydrochlor

6505011699573MP
CIICHCCESDPMICCriticalityENAC
U U
Part NumberISCRNVCRNCCHCCMSDSSADC
Ndc00186-1012-13523

Characteristics Data of NSN 6505-01-169-9573, 6505011699573

MRCCriteriaCharacteristic
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH80.000 MILLIGRAMS DOPAMINE PER MILLILITER
CBBLFEATURES PROVIDEDSTERILE
CQCTPRIMARY CONTAINER TYPEVIAL
CRLKPRIMARY CONTAINER CONTENT QUANTITY5.000 MILLILITERS
CSCWTOTAL PRIMARY CONTAINER QUANTITY25
FEATSPECIAL FEATURESNONPYROGENIC; TO BE DILUTED FOR INTRAVENOUS USE
MDESMEDICAL DESIGNATIONUNITED STATES PHARMACOPEIA